Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca AbfiledCriticalAstrazeneca Ab
Priority to UY29275ApriorityCriticalpatent/UY29275A1/en
Publication of UY29275A1publicationCriticalpatent/UY29275A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La invención proporciona compuestos de fórmula (I): en donde R1, R2, A, A1 y B son como se define en la memoria; los procesos para su preparación; las composiciones farmacéuticas que las contienen; un proceso para la preparación de las composiciones farmacéuticas; y su utilización en terapia. Los compuestos son útiles como inhibidores de las MMP.The invention provides compounds of formula (I): wherein R1, R2, A, A1 and B are as defined herein; the processes for its preparation; the pharmaceutical compositions containing them; a process for the preparation of pharmaceutical compositions; and its use in therapy. The compounds are useful as MMP inhibitors.
UY29275A2005-12-202005-12-20
NEW HIDANTOIN DERIVATIVES, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCESSES AND APPLICATIONS
UY29275A1
(en)